ENTITY
Jinxin Fertility

Jinxin Fertility (1951 HK)

126
Analysis
Health Care • China
Jinxin Fertility Group is a leading international provider of assisted reproductive services (ARS) and assisted reproductive technology (ART). Its core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), egg retrieval, embryo transfer, and genetic screening, alongside a range of women's health services. The company is headquartered in Chengdu, China, and was founded in 1951.
more
bullish•Jinxin Fertility
•14 Jan 2020 18:47

Jinxin Fertility (锦欣生殖) Placement - A Good Point of Entry

Shareholders of Jinxin Fertility Co Ltd (1951 HK) is looking to raise US$92m in an accelerated bookbuild. Ke Yan, CFA, FRM has covered the IPO...

Share
bullish•Jinxin Fertility
•06 Dec 2019 10:31

Jinxin Fertility Lock-Up Expiry Trade: Might Be Worth Doing a Reverse Enquiry

Stakes held by Jinxin Fertility’s pre-IPO investors and cornerstone investors, worth a total of USD 734 million (20% of the market cap), will be...

Logo
658 Views
Share
bullish•New Frontier Health
•21 Nov 2019 17:49

New Frontier Corp (和睦家) Trade - A Relisting with a Bigger Asset

New Frontier Corp (NFC) is seeking shareholder approval for the acquisition of UFH (United Family Healthcare) and share placements to fund the...

Logo
611 Views
Share
bullish•Quantitative Analysis
•30 Sep 2019 15:53

HK Connect Ideas: Sunny Optical, Shenzhou Intl, AIA, Weak Flows Ahead of Golden Week (2019-09-27)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
879 Views
Share
bullish•Quantitative Analysis
•23 Sep 2019 10:59

HK Connect Ideas: First Weekly Outflows in 19 Weeks, SMIC, Auto Sector (2019-09-20)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
781 Views
Share
x